<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31165490</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2125</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>85</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of clinical pharmacology</Title>
          <ISOAbbreviation>Br J Clin Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nonmedical use of alprazolam in the UK: Results from a nationally representative survey.</ArticleTitle>
        <Pagination>
          <StartPage>1841</StartPage>
          <EndPage>1845</EndPage>
          <MedlinePgn>1841-1845</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/bcp.13959</ELocationID>
        <Abstract>
          <AbstractText>There is concern in the UK about nonmedical use (NMU) of alprazolam (Xanax). We investigated the epidemiology of alprazolam NMU compared with diazepam using data from the Survey of Non-Medical Use of Prescription Drugs (NMURx) programme (collected 28 September-1 December 2017). The survey included 10 019 respondents and was weighted by age, sex and region to represent 52 927 659 UK adults. The estimated national prevalence of lifetime NMU of alprazolam was 0.32% (95% confidence interval: 0.19-0.46), and 1.30% (1.06-1.54) for diazepam. The prevalence of NMU in the last 90 days was significantly different when split by age category for alprazolam (P &lt; .001), but not for diazepam (P = .262) with alprazolam NMU being more common among younger adults (age 16-24 years: 0.37%; age 25-34 years: 0.14%; 35 years or older: 0.01%). Further research is needed to fully understand the motivations of alprazolam NMU and to monitor whether the popularity of alprazolam will rise.</AbstractText>
          <CopyrightInformation>© 2019 The British Pharmacological Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hockenhull</LastName>
            <ForeName>Joanna</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-3361-7598</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amioka</LastName>
            <ForeName>Elise</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Rocky Mountain Poison &amp; Drug Center, Denver Health and Hospital Authority, Denver, CO, 80204, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Black</LastName>
            <ForeName>Joshua C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Rocky Mountain Poison &amp; Drug Center, Denver Health and Hospital Authority, Denver, CO, 80204, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haynes</LastName>
            <ForeName>Colleen M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Rocky Mountain Poison &amp; Drug Center, Denver Health and Hospital Authority, Denver, CO, 80204, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dargan</LastName>
            <ForeName>Paul I</ForeName>
            <Initials>PI</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Life Sciences and Medicine, King's College London, London, WC2R 2LS, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dart</LastName>
            <ForeName>Richard C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>Rocky Mountain Poison &amp; Drug Center, Denver Health and Hospital Authority, Denver, CO, 80204, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wood</LastName>
            <ForeName>David M</ForeName>
            <Initials>DM</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Life Sciences and Medicine, King's College London, London, WC2R 2LS, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Br J Clin Pharmacol</MedlineTA>
        <NlmUniqueID>7503323</NlmUniqueID>
        <ISSNLinking>0306-5251</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000697">Central Nervous System Stimulants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>Q3JTX2Q7TU</RegistryNumber>
          <NameOfSubstance UI="D003975">Diazepam</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YU55MQ3IZY</RegistryNumber>
          <NameOfSubstance UI="D000525">Alprazolam</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000525" MajorTopicYN="N">Alprazolam</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000697" MajorTopicYN="N">Central Nervous System Stimulants</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003975" MajorTopicYN="N">Diazepam</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009042" MajorTopicYN="Y">Motivation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063487" MajorTopicYN="N">Prescription Drug Misuse</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">addiction</Keyword>
        <Keyword MajorTopicYN="Y">drug abuse</Keyword>
        <Keyword MajorTopicYN="Y">public health</Keyword>
      </KeywordList>
      <CoiStatement>The RADARS System is supported by subscriptions from pharmaceutical manufacturers, government and nongovernment agencies for surveillance, research and reporting services. RADARS System is the property of Denver Health and Hospital Authority, a political subdivision of the State of Colorado. Denver Health retains exclusive ownership of all data, databases and systems. Subscribers do not participate in data collection nor do they have access to the raw data. We declare no competing interests. Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust has been provided with funding from RADARS System to cover the time D.W., J.H. and P.D. spent on this study. D.W. and P.D. have received expenses and honorarium from RADARS System to present at the Annual RADARS system meeting.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31165490</ArticleId>
        <ArticleId IdType="pmc">PMC6624393</ArticleId>
        <ArticleId IdType="doi">10.1111/bcp.13959</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
BNF/NICE – Drug Guidelines. https://bnf.nice.org.uk/drug/. Accessed: March 26, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Fuentes A, Pineda M, Venkata K. Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice. Pharmacy (Basel). 2018;6(2):43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6025009</ArticleId>
            <ArticleId IdType="pubmed">29757930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
NHS digital – Prescription Cost Analysis. https://digital.nhs.uk/data‐and‐information/publications/statistical/prescription‐cost‐analysis. Accessed: March 26, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Ashton C H. Benzodiazepines how they work and how to withdraw (aka The Ashton Manual)
2002. 
https://www. benzo.org.uk/manual/index.htm. Accessed: March 26, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Brett J, Murnion B. Management of benzodiazepine misuse and dependence. Aust Prescr. 2015;38(5):152‐155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4657308</ArticleId>
            <ArticleId IdType="pubmed">26648651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ait‐Daoud N, Hamby AS, Sharma S, Blevins D. A review of alprazolam use, misuse, and withdrawal. J Addict Med. 2018;12(1):4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5846112</ArticleId>
            <ArticleId IdType="pubmed">28777203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Isbister GK, O'Regan L, Sibbritt D, Whyte IM. Alprazolam is relatively more toxic than other benzodiazepines in overdose. Br J Clin Pharmacol. 2004;58(1):88‐95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1884537</ArticleId>
            <ArticleId IdType="pubmed">15206998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gulland A. Sixty seconds on… Xanax. Br Med J. 2018;360:k659
10.1136/bmj.k659
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.k659</ArticleId>
            <ArticleId IdType="pubmed">29440060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Public Health England
. Alcohol and drug treatment for young people: statistics summary 2017 to 2018. https://www.gov.uk/government/publications/substance‐misuse‐treatment‐for‐young‐people‐statistics‐2017‐to‐2018/alcohol‐and‐drug‐treatment‐for‐young‐people‐statistics‐summary‐2017‐to‐2018#problem‐substances. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Beaumont‐Thomas B. The Guardian. Lil Xan: Total Xanarchy review – moronic rap to make you feel old. https://www.theguardian.com/music/2018/apr/05/lil‐xan‐total‐xanarchy‐review‐moronic‐rap‐to‐make‐you‐feel‐old. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Smyth C. The Times. Rap lyrics cause misuse of tranquilliser Xanax to soar. https://www.thetimes.co.uk/article/rap‐lyrics‐cause‐use‐of‐tranquilliser‐xanax‐to‐soar‐6mx8zb69t. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
BBC News
. Teenagers ill after taking prescription drug Xanax. https://www.bbc.co.uk/news/uk‐england‐wiltshire‐39855184. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Izundu C. BBC News. Xanax: Children as young as 11 taking anxiety drug. https://www.bbc.co.uk/news/health‐43431453. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Hansard Parliamentary Debate (House of Commons)
. Misuse of Xanax. https://hansard.parliament.uk/Commons/2018‐01‐15/debates/32F081A1‐E08F‐408E‐B3F5‐B74ABCE87335/MisuseOfXanax. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
O'Connor R. Public Health England. Alprazolam (Xanax): What are the facts?
https://publichealthmatters.blog.gov.uk/2018/07/30/alprazolam‐xanax‐what‐are‐the‐facts. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Wood DM, Green JL, Haynes CM, Rockhill KM, Dargan PI. Comparison of prevalence of illicit recreational drug use in the annual crime survey England and Wales and the UK survey of non‐medical use of prescription drugs Programme between 2014 and 2016. Clin Toxicol. 2017;55(5):445‐446.</Citation>
        </Reference>
        <Reference>
          <Citation>
Ng FL, Rockhill K, Black JC, et al. The UK survey of non‐medical use of prescription drugs (NMURx) as a valuable source of general population illicit drug use data. Postgrad Med J. 2018;94(1117):627‐633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30635430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Eurostat
. Population change ‐ Demographic balance and crude rates at regional level (NUTS3). http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=demo_r_gind3&amp;lang=en. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Lee D. The Guardian. Anxious teenagers buy Xanax on the dark web. https://www.theguardian.com/society/2018/jan/14/xanax‐anxious‐teenagers‐buy‐dark‐web‐tranquillisers. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Ewens H. Vice. How Xanax Became the British Teenager's Drug of Choice. https://www.vice.com/en_uk/article/ne4mvb/how‐british‐teens‐got‐hooked‐on‐xanax. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Future
. YouTube. 56 Nights [Official Video]. https://www.youtube.com/watch?v=DXXZ3J_QIGw. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Fletcher L. Independent. Lil Peep: SoundCloud rap pioneer who fell victim to the drug use and depression his music highlighted. https://www.independent.co.uk/news/obituaries/lil‐peep‐dead‐rap‐drug‐overdose‐soundcloud‐fentanyl‐youth‐drugs‐opioid‐crisis‐xanax‐a8129951.html. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Garland E
. Vice. How SoundCloud Rappers and Xanax Influenced Fashion. https://www.vice.com/en_uk/article/59kn3k/how‐soundcloud‐rappers‐and‐xanax‐influenced‐fashion. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Lil Xan (@xanxiety)
. Instagram account. https://www.instagram.com/xanxiety/?hl=en. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Lil pump (@lilpump)
. Instagram. A XAN cake for celebration. https://www.instagram.com/p/BVafPbSFQWm/?hl=en. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Brown A. Daily Star. Music by rap legends Eminem and Lil Wayne to blame for teens' Xanax binges. https://www.dailystar.co.uk/news/latest‐news/688649/Eminem‐Lil‐Wayne‐Xanax‐drug‐addiction‐UK‐teens. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Marsh S. The Guardian. Xanax misuse: doctors warn of 'emerging crisis' as UK sales rise
https://www.theguardian.com/society/2018/feb/05/xanax‐misuse‐uk‐dark‐web‐sales‐health. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
The US Food and Drug Administration, BeSafeRx: Survey Highlights. https://wayback.archive‐it.org/7993/20170722175833/https://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/BuyingMedicinesOvertheInternet/BeSafeRxKnowYourOnlinePharmacy/ucm318497.htm. Accessed: February 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Mackey TK, Liang BA, Strathdee SA. Digital social media, youth, and nonmedical use of prescription drugs: the need for reform. J Med Internet Res. 2013;15(7):e143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3742396</ArticleId>
            <ArticleId IdType="pubmed">23892156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
National Survey on Drug Use and Health, 2017. 
https://datafiles.samhsa.gov/study‐dataset/national‐survey‐drug‐use‐and‐health‐2017‐nsduh‐2017‐ds0001‐nid17939. Accessed: March 26, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>
Schaffer AL, Buckley NA, Cairns R, Pearson SA. Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: taking control of prescription drug use. JAMA Intern Med. 2016.  Aug 1;176(8):1223‐1225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27379377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ong AD, Weiss DJ. The impact of anonymity on responses to sensitive questions 1. J Appl Soc Psychol. 2000;30(8):1691‐1708.</Citation>
        </Reference>
        <Reference>
          <Citation>
Global Drug Survey. https://www.globaldrugsurvey.com. Accessed: February 12, 2019.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
